These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10097893)

  • 1. Immunologic "vaccination" for the prevention of autoimmune diabetes (type 1A).
    Simone EA; Wegmann DR; Eisenbarth GS
    Diabetes Care; 1999 Mar; 22 Suppl 2():B7-15. PubMed ID: 10097893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of autoimmune diabetes by antigen based immune modulation: are we there yet?
    Bot A; von Herrath M
    Minerva Med; 2004 Apr; 95(2):105-14. PubMed ID: 15272245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
    Glinka Y; Chang Y; Prud'homme GJ
    Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Chen YG
    Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental autoimmune diabetes: a new tool to study mechanisms and consequences of insulin-specific autoimmunity.
    Rajasalu T; Barth C; Spyrantis A; Durinovic-Belló I; Uibo R; Schirmbeck R; Boehm BO; Karges W
    Ann N Y Acad Sci; 2004 Dec; 1037():208-15. PubMed ID: 15699519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in Type 1 diabetes.
    Schmidt KD; Valeri C; Leslie RD
    Clin Chim Acta; 2005 Apr; 354(1-2):35-40. PubMed ID: 15748597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucosal insulin vaccination for type 1 diabetes prevention.
    Bonifacio E; Achenbach P; Pan L; Ziegler AG
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S26-9. PubMed ID: 18777449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccination to treat autoimmune diabetes.
    von Herrath MG; Whitton JL
    Ann Med; 2000 Jul; 32(5):285-92. PubMed ID: 10949059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptors and autoimmune-mediated diabetes.
    Wang XP; Norman MA; Brunicardi FC
    Diabetes Metab Res Rev; 2005; 21(1):15-30. PubMed ID: 15624122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of insulin-dependent diabetes.
    Liu E; Yu L; Moriyama H; Eisenbarth GS
    Methods Mol Med; 2004; 102():195-212. PubMed ID: 15286387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction with agonist peptides recognized by autoaggressive lymphocytes is transient: therapeutic potential for type 1 diabetes is limited and depends on time-point of administration, choice of epitope and adjuvant.
    von Herrath MG; Coon B; Wolfe T
    J Autoimmun; 2001 May; 16(3):193-9. PubMed ID: 11334483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-specific tolerance in diabetes.
    Gottlieb PA; Eisenbarth GS
    Clin Immunol; 2002 Jan; 102(1):2-11. PubMed ID: 11781061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
    Li A; Ojogho O; Franco E; Baron P; Iwaki Y; Escher A
    Vaccine; 2006 Jun; 24(23):5036-46. PubMed ID: 16621191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.